Cancer Immunology and Immunotherapy has seen significant advances in the field of tumor immunology. Cancer Immunology and Immunotherapy deal with broad-ranging ideas and reviews, results which extend or challenge established paradigms as well as negative studies which fail to reproduce experiments that support current paradigms and papers that do succeed in reproducing others’ results in different contexts. Cancer Immunology and Immunotherapy specially deals with understanding clinical trial designs and outcome regardless of whether they met their designated endpoints or not and particularly those shedding light on immunological mechanisms. Cancer Immunology and Immunotherapy also deals with the studies on new concepts and advances in basic, translational, and clinical cancer immunology and immunotherapy. This session discusses more about cancer immunology and immunotherapy.